Immunological evaluation of a streptococcal preparation (OK-432) in treatment of bladder carcinoma.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Journal of Urology

• Publication date

  1979-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(17)56466-6PMID 480487
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Experimental studies of effects of the streptococcal anticancer preparation (Picibanil) for bladder carcinomas of ACI/N rats (author's transl)].

  1976cited by this paper
• Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.

  1976cited by this paper
• LYMPHOID CELLS MEDIATING TUMOR-SPECIFIC CYTOTOXICITY TO CARCINOMA OF THE URINARY BLADDER

  1974cited by this paper
• Immune response to urinary bladder tumours in man

  1970cited by this paper
• The role of lymphoid reaction in bladder cancer.

  1970cited by this paper
• Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci.

  1967cited by this paper

• Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration

  2012cites this paper
• Keyhole-Limpet Haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma

  2004cites this paper
• Cytokine-mediated antitumor effect of OK-432 on urinary bladder tumor cells in vitro

  2004cites this paper
• Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma

  2004cites this paper
• Immunologic parameters in patients with thyroid cancer

  2004cites this paper
• Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N -butyl-N -(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response

  2000cites this paper
• Bacillus Calmette-Guerin (BCG) in the treatment of superficial bladder cancer.

  1997cites this paper
• Immunotherapy and Gene Therapy for Genitourinary Malignancies

  1996cites this paper
• The streptococcal preparation ok‐432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytes

  1992cites this paper
• Immunoresponse of tissue infiltrating lymphocytes in bladder tumors.

  1989cites this paper
• [Anti-tumor effect of LAK (lymphokine activated killer) cells against human bladder tumors transplanted to nude mouse].

  1989cites this paper
• Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.

  1988cites this paper
• [A study of immune surveillance for bladder tumor. II. Immunoresponse of tissue infiltrating lymphocytes following immunomodulator injection in bladder tumors].

  1988cites this paper
• Superficial bladder cancer.

  1985cites this paper
• Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review

  1985cites this paper
• Superficial bladder cancer.

  1985cites this paper
• The biology and treatment of superficial bladder cancer.

  1984cites this paper
• Immunotherapy of superficial bladder cancer.

  1982cites this paper
• Immunology of Genitourinary Tumors

  1982cites this paper
• Genitourinary Cancer 1

  1982cites this paper